WellSync and Marius Pharmaceuticals Collaborate to Offer FDA-approved Oral TRT, Expanding Virtual Care for Men’s Health
WellSync collaborates with Marius Pharmaceuticals to offer KYZATREX®, an oral form of TRT, on WellSync’s virtual care platform, demonstrating WellSync’s ability to deliver a direct-to-patient healthcare solution.
